Researchers at the Montreal Heart Institute in Canada are currently studying the role of colchicine in reducing inflammation and lung complications in patients with mild symptoms of COVID-19.
Watafiti kutoka Taasisi ya Moyo huko Montreal kwa sasa wanachunguza jukumu la colchicine katika kupunguza uvimbe na matatizo ya mapafu kwa wagonjwa wenye dalili kazi za COVID-19.